ASBPW
Aspire-Lakewood Holdings, Inc.
Price Chart
Latest Quote
$0.02
+0.00 (+0.00%)
Current Price
| Previous Close | $0.02 |
| Open | $0.04 |
| Day High | $0.02 |
| Day Low | $0.02 |
| Volume | 6,000 |
Stock Information
| Cash Equivalents | $12.17M |
| Revenue | $98K |
| Net Income | $-11.05M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $98K |
| Income | $-11.05M |
| Book/sh | $9.08 |
Financial Ratios
| Quick Ratio | 7.22 |
| Current Ratio | 7.99 |
Returns & Margins
| ROA | 60.58% |
| ROE | -1032.14% |
| Gross Margin | -25.04% |
| Operating Margin | -3880.58% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| Shares Float | 1.12M |
| Volatility | 0.17 |
Performance History
| YTD | +0.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-23 | $0.02 | 6,000 |
About Aspire-Lakewood Holdings, Inc.
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lead prescription product candidate, Sublingual High Dose Aspirin, targets pain management and anti-inflammatory applications. The company also develops Alprazolam in a sublingual formulation for anxiety treatment and offers Buzz Bomb Caffeine, a sublingually administered caffeine pre-workout consumer supplement. Additionally, it develops sublingual formulations of Melatonin for sleep aid, Sublingual ED for erectile dysfunction, testosterone products, and vitamins D, E, and K. The company targets therapeutic applications including heart attack and stroke, anxiety, antiplatelet conditions, nausea, pain management, and inflammation. The company also designs and manufactures engineered control systems that integrate mechanical engineering, electronics, and computer science for body, chassis, powertrain, electrical, and interior vehicle applications. It offers HMI and actuation systems, safety systems, shift systems, pedal systems, park systems, mechanical control cables, and mechatronic systems. Aspire-Lakewood Holdings, Inc. was formerly known as Aspire Biopharma Holdings, Inc. and changed its name to Aspire-Lakewood Holdings, Inc. in September 2026. Aspire-Lakewood Holdings, Inc. was incorporated in 2021 and is based in Estero, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on ASBPW.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,318 | $0 | $0 | $0 |
| Cost Of Revenue | $6,318 | $0 | $0 | $0 |
| Total Revenue | $6,202 | $0 | $0 | $0 |
| Operating Revenue | $6,202 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $8,531,275 | $97,988 | $8,966 | $0 |
| Total Expenses | $19,357,493 | $1,210,871 | $1,340,168 | $596,491 |
| Other Income Expense | $3,401,718 | $-9,105,853 | - | - |
| Other Non Operating Income Expenses | $3,860,889 | $-9,105,853 | - | - |
| Net Non Operating Interest Income Expense | $-8,531,275 | $-97,988 | $5,804,247 | $0 |
| Interest Expense Non Operating | $8,531,275 | $97,988 | $8,966 | $0 |
| Operating Expense | $19,351,175 | $1,210,871 | $1,340,168 | $596,491 |
| Selling And Marketing Expense | $789,829 | $126,094 | $39,644 | $45,483 |
| General And Administrative Expense | $17,637,432 | $940,421 | $1,340,168 | $375,692 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-24,480,848 | $-1,309,872 | $4,464,079 | $-597,117 |
| Net Interest Income | $-8,531,275 | $-97,988 | $5,804,247 | $0 |
| Normalized Income | $-24,021,677 | $-1,309,872 | $4,464,079 | $-597,117 |
| Net Income From Continuing And Discontinued Operation | $-24,480,848 | $-1,309,872 | $4,464,079 | $-597,117 |
| Net Income Common Stockholders | $-24,480,848 | $-1,309,872 | $4,464,079 | $-597,117 |
| Net Income | $-24,480,848 | $-1,309,872 | $4,464,079 | $-597,117 |
| Net Income Including Noncontrolling Interests | $-24,480,848 | $-1,309,872 | $4,464,079 | $-597,117 |
| Net Income Continuous Operations | $-24,480,848 | $-1,309,872 | $4,464,079 | $-597,117 |
| Pretax Income | $-24,480,848 | $-1,308,859 | $4,464,079 | $-596,491 |
| Special Income Charges | $-364,109 | $0 | - | - |
| Operating Income | $-19,351,291 | $-1,210,871 | $-1,340,168 | $-596,491 |
| Gross Profit | $-116 | $0 | $0 | $0 |
| Interest Income | - | $548,676 | $5,813,213 | - |
| Interest Income Non Operating | - | $548,676 | $5,813,213 | - |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-15,490,402 | $-1,210,871 | $4,473,045 | $-596,491 |
| Total Unusual Items | $-459,171 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $-459,171 | $0 | - | - |
| EBITDA (Bullshit earnings) | $-15,949,573 | $-1,210,871 | $4,473,045 | $-596,491 |
| EBIT | $-15,949,573 | $-1,210,871 | $4,473,045 | $-596,491 |
| Diluted NI Availto Com Stockholders | $-24,480,848 | $-1,309,872 | $4,464,079 | $-597,117 |
| Tax Provision | $0 | $1,013 | $481 | $626 |
| Other Special Charges | $364,109 | - | - | - |
| Gain On Sale Of Security | $-95,062 | - | - | - |
| Research And Development | $923,914 | $144,356 | $72,050 | $175,316 |
| Selling General And Administration | $18,427,261 | $1,066,515 | $1,340,168 | $421,175 |
| Other Gand A | $17,637,432 | $940,421 | $1,340,168 | $375,692 |
| Reconciled Depreciation | - | $0 | $0 | $0 |
Fetched: 2026-10-26
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-6,376,329 | $-1,540,088 | $-487,861 | $-128,790 |
| Total Assets | $1,312,166 | $147,989 | $46,174 | $22,538 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $1,312,166 | $147,989 | $46,174 | $22,538 |
| Other Current Assets | $55,102 | $144,356 | $35,000 | $22,500 |
| Prepaid Assets | $55,102 | $144,356 | $35,000 | $22,500 |
| Inventory | $253,160 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $1,003,904 | $3,633 | $11,174 | $38 |
| Cash And Cash Equivalents | $1,003,904 | $3,633 | $11,174 | $38 |
| Cash Financial | $1,003,904 | $3,633 | $11,174 | $38 |
| Receivables | - | $0 | $0 | $0 |
| Goodwill And Other Intangible Assets | - | - | $4,971,007 | $4,895,106 |
| Debt | ||||
| Net Debt | $4,171,350 | $1,263,199 | $349,462 | $27,929 |
| Total Debt | $5,175,254 | $1,266,832 | $360,636 | $27,967 |
| Current Debt And Capital Lease Obligation | $5,175,254 | $1,266,832 | $360,636 | $27,967 |
| Current Debt | $5,175,254 | $1,266,832 | $360,636 | $27,967 |
| Other Current Borrowings | $2,790,476 | $1,266,832 | $360,636 | $27,967 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,688,495 | $1,688,077 | $534,035 | $151,328 |
| Total Non Current Liabilities Net Minority Interest | $95,662 | $0 | $0 | $1 |
| Derivative Product Liabilities | $95,662 | $0 | - | - |
| Current Liabilities | $7,592,833 | $1,688,077 | $534,035 | $151,327 |
| Other Current Liabilities | $40,954 | $111,026 | $626 | $626 |
| Current Notes Payable | $2,384,778 | $1,266,832 | - | - |
| Payables And Accrued Expenses | $2,376,625 | $310,219 | $172,773 | $122,734 |
| Payables | $1,368,056 | $310,219 | $172,773 | $122,734 |
| Accounts Payable | $1,014,377 | $310,219 | $172,773 | $122,734 |
| Other Non Current Liabilities | - | - | $3,852,552 | $3,852,553 |
| Equity | ||||
| Common Stock Equity | $-6,376,329 | $-1,540,088 | $-487,861 | $-128,790 |
| Total Equity Gross Minority Interest | $-6,376,329 | $-1,540,088 | $-487,861 | $-128,790 |
| Stockholders Equity | $-6,376,329 | $-1,540,088 | $-487,861 | $-128,790 |
| Retained Earnings | $-27,258,081 | $-2,777,233 | $-1,467,361 | $-1,108,290 |
| Preferred Stock Equity | - | $32 | - | - |
| Other | ||||
| Ordinary Shares Number | $117,780 | $38,339 | $38,339 | $38,339 |
| Share Issued | $117,780 | $38,339 | $38,339 | $38,339 |
| Tangible Book Value | $-6,376,329 | $-1,540,088 | $-487,861 | $-128,790 |
| Invested Capital | $-1,201,075 | $-273,256 | $-127,225 | $-100,823 |
| Working Capital | $-6,280,667 | $-1,540,088 | $-487,861 | $-128,789 |
| Total Capitalization | $-6,376,329 | $-1,540,088 | $-487,861 | $-128,790 |
| Additional Paid In Capital | $20,881,399 | $1,237,076 | $957,500 | $758,000 |
| Capital Stock | $353 | $69 | $22,000 | $221,500 |
| Common Stock | $353 | $69 | $22,000 | $221,500 |
| Preferred Stock | $0 | $0 | $0 | - |
| Current Accrued Expenses | $1,008,569 | $0 | - | - |
| Dueto Related Parties Current | $353,679 | $0 | - | - |
Fetched: 2026-10-26
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,923,488 | $-265,186 | $11,136 | $-5,038,011 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,923,488 | $-265,186 | $11,136 | $-142,905 |
| Cash Flow From Continuing Operating Activities | $-4,923,488 | $-265,186 | $11,136 | $-142,905 |
| Operating Gains Losses | $-3,401,718 | - | - | - |
| Investing Activities | ||||
| Investing Cash Flow | - | $0 | $0 | $-4,895,106 |
| Capital Expenditure | - | - | $-75,902 | $-4,895,106 |
| Cash Flow From Continuing Investing Activities | - | - | $-75,902 | $-4,895,106 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $265,827 | $257,645 | $0 | $1,000,000 |
| Financing Cash Flow | $5,923,759 | $257,645 | $0 | $4,852,552 |
| Cash Flow From Continuing Financing Activities | $5,923,759 | $257,645 | $0 | $4,852,552 |
| Net Other Financing Charges | $-907,499 | - | - | $3,852,552 |
| Net Common Stock Issuance | $265,827 | $257,645 | $0 | $1,000,000 |
| Common Stock Issuance | $265,827 | $257,645 | $0 | $1,000,000 |
| Other | ||||
| Repayment Of Debt | $-3,734,569 | $0 | - | - |
| Issuance Of Debt | $10,300,000 | $0 | - | - |
| Interest Paid Supplemental Data | $44,388 | $0 | $0 | - |
| End Cash Position | $1,003,904 | $3,633 | $11,174 | $38 |
| Beginning Cash Position | $3,633 | $11,174 | $38 | $185,496 |
| Changes In Cash | $1,000,271 | $-7,541 | $11,136 | $-185,458 |
| Net Issuance Payments Of Debt | $6,565,431 | $0 | - | - |
| Net Short Term Debt Issuance | $6,565,431 | $0 | - | - |
| Short Term Debt Payments | $-3,734,569 | $0 | - | - |
| Short Term Debt Issuance | $10,300,000 | $0 | - | - |
| Change In Working Capital | $533,380 | $1,044,686 | $370,206 | $454,212 |
| Change In Other Current Liabilities | $-111,026 | $906,196 | $332,668 | $-68,576 |
| Change In Payables And Accrued Expense | $723,312 | $247,846 | $50,038 | $145,288 |
| Change In Accrued Expense | $1,047,088 | $0 | $75,902 | $42,554 |
| Change In Payable | $-323,776 | $247,846 | $50,038 | $102,734 |
| Change In Account Payable | $-323,776 | $247,846 | $50,038 | $102,734 |
| Change In Prepaid Assets | $174,254 | $-109,356 | $-12,500 | $-22,500 |
| Change In Inventory | $-253,160 | $0 | - | - |
| Other Non Cash Items | $8,294,448 | - | - | - |
| Stock Based Compensation | $14,131,250 | $0 | - | - |
| Gain Loss On Investment Securities | $-3,765,827 | - | - | - |
| Net Income From Continuing Operations | $-24,480,848 | $-1,309,872 | $-359,070 | $-597,117 |
| Income Tax Paid Supplemental Data | - | $1,013 | $0 | - |
| Change In Receivables | - | $0 | $0 | $400,000 |
| Depreciation Amortization Depletion | - | $0 | $0 | $0 |
| Depreciation And Amortization | - | $0 | $0 | $0 |
| Net Intangibles Purchase And Sale | - | - | $-75,902 | $-4,895,106 |
Fetched: 2026-10-26